The high-sensitivity C-reactive protein (hsCRP) assay is a quantitative analysis test of very low levels of C-reactive protein (CRP) in the blood. The hsCRP assay is being increasingly used as a marker for cardiac risk assessment and as a prognostic tool in heart disease. The CRP test, in addition to lipid evaluation and global risk scoring systems, helps in the evaluation of cardiovascular disease risk in an individual.
- Helps in the evaluation of cardiovascular disease risk in individuals
- Enhances risk assessment and therapeutic outcomes in primary CVD prevention
- Recommended as a more sensitive assay for predicting vascular disease
- Particularly advantageous for assessing the risk in patients with Framingham 10-year risk scores of 10%-20% and/or LDL levels of <160